Region:Middle East
Author(s):Geetanshi
Product Code:KRAE0596
Pages:80
Published On:December 2025

By Type:The market is segmented into various types of ECMO systems, including Veno-venous ECMO, Veno-arterial ECMO, Arterio-venous ECMO, and others. Among these, Veno-venous ECMO is the most widely used due to its effectiveness in providing respiratory support for patients with severe lung conditions. The increasing prevalence of respiratory diseases and the need for advanced life support systems in critical care settings are driving the demand for this sub-segment.

By End-User:The end-user segmentation includes Hospitals, Specialty Clinics, Research Institutions, and others. Hospitals dominate this segment due to their comprehensive critical care facilities and the increasing number of patients requiring ECMO support. The growing number of specialized cardiac and respiratory care units within hospitals is further propelling the demand for ECMO machines.

The Middle East Extracorporeal Membrane Oxygenation Machine Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic, Getinge Group, LivaNova, Terumo Corporation, Abbott Laboratories, Fresenius SE & Co. KGaA, Nihon Kohden Corporation, Maquet Getinge Group, Sorin Group, XENIOS AG, ELSA Medica, A.L.S. Medical, Intersurgical, Medela AG, AtriCure, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The future of the ECMO machine market in the Middle East appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As governments prioritize healthcare infrastructure, the demand for ECMO systems is expected to rise. Additionally, the integration of artificial intelligence in ECMO management will enhance operational efficiency. These trends indicate a shift towards more accessible and effective respiratory care solutions, positioning the market for significant growth in the coming years.
| Segment | Sub-Segments |
|---|---|
| By Type | Veno-venous ECMO Veno-arterial ECMO Arterio-venous ECMO Others |
| By End-User | Hospitals Specialty Clinics Research Institutions Others |
| By Application | Cardiac Support Respiratory Support Extracorporeal Carbon Dioxide Removal Others |
| By Patient Type | Adult Patients Pediatric Patients Neonatal Patients Others |
| By Region | GCC Countries Levant Region North Africa Others |
| By Distribution Channel | Direct Sales Distributors Online Sales Others |
| By Technology | Conventional ECMO Systems Portable ECMO Systems Hybrid ECMO Systems Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Cardiology Departments | 100 | Cardiologists, Department Heads |
| Pulmonary Care Units | 80 | Pulmonologists, Critical Care Nurses |
| Hospital Procurement Teams | 70 | Procurement Managers, Supply Chain Directors |
| Biomedical Engineering Departments | 60 | Biomedical Engineers, Equipment Technicians |
| Healthcare Policy Makers | 50 | Health Administrators, Policy Analysts |
The Middle East Extracorporeal Membrane Oxygenation Machine Market is valued at approximately USD 15 million, reflecting a five-year historical analysis that highlights growth driven by healthcare investments and the demand for advanced critical care infrastructure.